Overview
Owlet Q2 revenue grows 25.9% yr/yr, beating analyst expectations, per LSEG data
Co announces CEO transition with Jonathan Harris succeeding Kurt Workman
Outlook
Owlet expects 2025 revenue between $97 mln and $100 mln
Company anticipates 2025 gross margins of 46% to 50%
Result Drivers
PRODUCT SALES - Higher sales of Dream Sock and Dream Duo products drove revenue growth
GROSS MARGIN IMPROVEMENT - Gross margin increased due to favorable product mix and lower costs
SUBSCRIPTION GROWTH - Owlet360 subscription surpassed 66,000 paying subscribers, boosting recurring revenue
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Revenue
Beat
$26.10 mln
$22.20 mln (4 Analysts)
Q2 Adjusted EPS
Beat
-$0.05
-$0.22 (3 Analysts)
Q2 EPS
-$2.37
Q2 Gross Margin
51.3%
Q2 Operating Expenses
$15.30 mln
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Owlet Inc is $11.50, about 38.3% above its August 6 closing price of $7.10
Press Release: ID:nBw8HX093a
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)